vs

Side-by-side financial comparison of Armour Residential REIT, Inc. (ARR) and Liquidia Corp (LQDA). Click either name above to swap in a different company.

Liquidia Corp is the larger business by last-quarter revenue ($92.0M vs $50.4M, roughly 1.8× Armour Residential REIT, Inc.). Armour Residential REIT, Inc. runs the higher net margin — 420.2% vs 15.8%, a 404.4% gap on every dollar of revenue. On growth, Liquidia Corp posted the faster year-over-year revenue change (3054.6% vs 297.9%).

Armour Residential REIT, Inc. is a U.S.-based real estate investment trust that primarily invests in agency residential mortgage-backed securities guaranteed by U.S. government-sponsored entities. It focuses on generating consistent long-term net income for shareholders via strategic asset management and active interest rate risk mitigation.

Liquidia Corp is a late-stage biopharmaceutical firm focused on developing and commercializing innovative inhaled therapies for respiratory and rare diseases. It uses its proprietary PRINT particle engineering tech to create optimized drug products, with core markets in North America covering pulmonary arterial hypertension and asthma indications.

ARR vs LQDA — Head-to-Head

Bigger by revenue
LQDA
LQDA
1.8× larger
LQDA
$92.0M
$50.4M
ARR
Growing faster (revenue YoY)
LQDA
LQDA
+2756.8% gap
LQDA
3054.6%
297.9%
ARR
Higher net margin
ARR
ARR
404.4% more per $
ARR
420.2%
15.8%
LQDA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARR
ARR
LQDA
LQDA
Revenue
$50.4M
$92.0M
Net Profit
$211.7M
$14.6M
Gross Margin
Operating Margin
21.5%
Net Margin
420.2%
15.8%
Revenue YoY
297.9%
3054.6%
Net Profit YoY
555.9%
137.9%
EPS (diluted)
$2.43
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARR
ARR
LQDA
LQDA
Q4 25
$50.4M
$92.0M
Q3 25
$38.5M
$54.3M
Q2 25
$33.1M
Q1 25
$36.3M
Q4 24
$12.7M
Q2 24
$7.0M
Q1 23
$12.2M
Q4 22
$11.6M
Net Profit
ARR
ARR
LQDA
LQDA
Q4 25
$211.7M
$14.6M
Q3 25
$159.3M
$-3.5M
Q2 25
$-75.6M
Q1 25
$27.3M
Q4 24
$-46.4M
Q2 24
$-48.4M
Q1 23
$-31.4M
Q4 22
Operating Margin
ARR
ARR
LQDA
LQDA
Q4 25
21.5%
Q3 25
3.3%
Q2 25
Q1 25
Q4 24
Q2 24
Q1 23
Q4 22
Net Margin
ARR
ARR
LQDA
LQDA
Q4 25
420.2%
15.8%
Q3 25
413.5%
-6.5%
Q2 25
-228.4%
Q1 25
75.2%
Q4 24
-366.8%
Q2 24
-693.8%
Q1 23
-256.8%
Q4 22
EPS (diluted)
ARR
ARR
LQDA
LQDA
Q4 25
$2.43
$0.18
Q3 25
$1.49
$-0.04
Q2 25
$-0.94
Q1 25
$0.32
Q4 24
$-0.91
Q2 24
$-1.05
Q1 23
$-0.95
Q4 22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARR
ARR
LQDA
LQDA
Cash + ST InvestmentsLiquidity on hand
$63.3M
$190.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.3B
$44.7M
Total Assets
$21.0B
$327.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARR
ARR
LQDA
LQDA
Q4 25
$63.3M
$190.7M
Q3 25
$44.2M
$157.5M
Q2 25
$141.2M
Q1 25
$49.1M
Q4 24
$68.0M
Q2 24
$126.6M
Q1 23
Q4 22
$87.3M
Stockholders' Equity
ARR
ARR
LQDA
LQDA
Q4 25
$2.3B
$44.7M
Q3 25
$2.1B
$22.1M
Q2 25
$1.7B
Q1 25
$1.7B
Q4 24
$1.4B
Q2 24
$1.2B
Q1 23
$1.2B
Q4 22
$1.1B
Total Assets
ARR
ARR
LQDA
LQDA
Q4 25
$21.0B
$327.9M
Q3 25
$19.4B
$276.0M
Q2 25
$16.2B
Q1 25
$15.5B
Q4 24
$13.5B
Q2 24
$10.1B
Q1 23
$13.2B
Q4 22
$9.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARR
ARR
LQDA
LQDA
Operating Cash FlowLast quarter
$124.2M
$44.2M
Free Cash FlowOCF − Capex
$42.2M
FCF MarginFCF / Revenue
45.9%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
0.59×
3.04×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARR
ARR
LQDA
LQDA
Q4 25
$124.2M
$44.2M
Q3 25
$-37.8M
$-9.8M
Q2 25
$25.0M
Q1 25
$101.5M
Q4 24
$261.5M
Q2 24
$27.1M
Q1 23
$54.2M
Q4 22
$124.1M
Free Cash Flow
ARR
ARR
LQDA
LQDA
Q4 25
$42.2M
Q3 25
$-10.7M
Q2 25
Q1 25
Q4 24
Q2 24
Q1 23
Q4 22
FCF Margin
ARR
ARR
LQDA
LQDA
Q4 25
45.9%
Q3 25
-19.7%
Q2 25
Q1 25
Q4 24
Q2 24
Q1 23
Q4 22
Capex Intensity
ARR
ARR
LQDA
LQDA
Q4 25
2.2%
Q3 25
1.7%
Q2 25
Q1 25
Q4 24
Q2 24
Q1 23
Q4 22
Cash Conversion
ARR
ARR
LQDA
LQDA
Q4 25
0.59×
3.04×
Q3 25
-0.24×
Q2 25
Q1 25
3.71×
Q4 24
Q2 24
Q1 23
Q4 22

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons